MRVICIK 1823239

MARAVAI LIFESCIENCES HOLDINGS, INC.

EDGAR filings

Customers

2 active

Suppliers

None disclosed

Largest customer

21.7%

PFE · 3M to 2026-03-31

Named-customer revenue

$14.3M

1 customer · 3M to 2026-03-31

Latest period

Mar 31, 2026

10-Q filed 2026-05-08

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available). Thin bands are named without a figure. Click a band to open its filing.

Customers 2

Companies MRVI discloses as major customers, as a share of MRVI revenue. 2 active, 0 lapsed.

Company	% of MRVI revenue	Est. revenue	Period	Trend	Status	Source
PFE PFIZER INC	21.7%	$14.3M	3M 2026-03-31		Active	10-Q 2026-05-08
Pfizer, Inc. 21.7 % * 15.6 % * 10-Q filed 2026-05-08 Period 3M 2026-01-01 to 2026-03-31 (21.7%)Accession 0001823239-26-000024
Nacalai USA, Inc Non-SEC Nacalai USA, Inc	Named	—	FY 2025-12-31	+1.5pp	Active	10-K 2026-02-26
Nacalai USA, Inc. * 20.8 % 19.3 % 12.0 % 36.8 % 10-K filed 2026-02-26 Period FY 2025-01-01 to 2025-12-31, FY 2024-01-01 to 2024-12-31 (20.8%), FY 2023-01-01 to 2023-12-31 (19.3%)Accession 0001823239-26-000011 Nacalai USA, Inc. * 21.1 % * 19.5 % * 36.8 % 10-Q filed 2025-11-07 Period 3M 2024-07-01 to 2024-09-30 (21.1%)Accession 0001823239-25-000120

Alerts are coming

Get an email when MRVI's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.